• Home
  • Advanced Search
  • Directory of Libraries
  • About lib.ir
  • Contact Us
  • History

عنوان
Contraceptive Effect of a Recombinant GnRH Vaccine in Adult Female Pigs

پدید آورنده
Miller, Lowell A.; Talwar, G. P.; Killian, Gary J.,Miller, Lowell A.; Talwar, G. P.; Killian, Gary J.

موضوع

رده

کتابخانه
Center and Library of Islamic Studies in European Languages

محل استقرار
استان: Qom ـ شهر: Qom

Center and Library of Islamic Studies in European Languages

تماس با کتابخانه : 32910706-025

NATIONAL BIBLIOGRAPHY NUMBER

Number
LA1255f13r

LANGUAGE OF THE ITEM

.Language of Text, Soundtrack etc
انگلیسی

TITLE AND STATEMENT OF RESPONSIBILITY

Title Proper
Contraceptive Effect of a Recombinant GnRH Vaccine in Adult Female Pigs
General Material Designation
[Article]
First Statement of Responsibility
Miller, Lowell A.; Talwar, G. P.; Killian, Gary J.

SUMMARY OR ABSTRACT

Text of Note
GonaCon™ is a gonadotropin releasing hormone (GnRH) contraceptive vaccine developed at the USDA National Wildlife Research Center (NWRC) that contains keyhole limpet hemocyanin (KLH) coupled to GnRH. The vaccine is administered intramuscularly in an emulsion with the NWRC adjuvant, AdjuVac™. This first-generation vaccine, developed in 1998, has been very effective in contracepting every species tested. However, because of the high cost of KLH, NWRC has developed a second generation GnRH vaccine, replacing KLH with a less expensive mollusk protein. This second generation GnRH vaccine, called GonaCon-Blue™, is currently being tested in several species and has proven to be as, or more effective than the original GonaCon™. Scientists with the Reproductive Control Methods Project at the NWRC are also testing a recombinant GnRH antigen developed by Dr. Talwar of the Talwar Research Institute, India. The recombinant antigen was produced from plasmid gene expression grown in and extracted from E. coli. The antigen is combined with the NWRC AdjuVac™ to form an emulsion similar to the GonaCon™ preparation. The recombinant vaccine has been shown to be effective as a single or dual injection for contraception of adult female pigs in a short-term study at the Swine Research Facility at Penn State University. Although the long term effectiveness of the recombinant vaccine remains to be established, this small molecule of approximately 14,000 MW is of considerable interest because it may be effective in oral or transcutaneous applications. It could also be scaled-up for large field applications.

SET

Date of Publication
2006
Title
Proceedings of the Vertebrate Pest Conference
Volume Number
22

PERSONAL NAME - PRIMARY RESPONSIBILITY

Entry Element
Miller, Lowell A.; Talwar, G. P.; Killian, Gary J.

ELECTRONIC LOCATION AND ACCESS

Electronic name
 مطالعه متن کتاب 

[Article]
275578

a
Y

Proposal/Bug Report

Warning! Enter The Information Carefully
Send Cancel
This website is managed by Dar Al-Hadith Scientific-Cultural Institute and Computer Research Center of Islamic Sciences (also known as Noor)
Libraries are responsible for the validity of information, and the spiritual rights of information are reserved for them
Best Searcher - The 5th Digital Media Festival